[go: up one dir, main page]

WO2006125025A3 - Engineered extracellular matrices control stem cell behavior - Google Patents

Engineered extracellular matrices control stem cell behavior Download PDF

Info

Publication number
WO2006125025A3
WO2006125025A3 PCT/US2006/019130 US2006019130W WO2006125025A3 WO 2006125025 A3 WO2006125025 A3 WO 2006125025A3 US 2006019130 W US2006019130 W US 2006019130W WO 2006125025 A3 WO2006125025 A3 WO 2006125025A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cell
cell behavior
extracellular matrices
control stem
engineered extracellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/019130
Other languages
French (fr)
Other versions
WO2006125025A2 (en
Inventor
Sherry L Voytik-Harbin
Beverly Z Waisner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Priority to AU2006247228A priority Critical patent/AU2006247228B2/en
Priority to GB0724345A priority patent/GB2441268B/en
Priority to CA2608422A priority patent/CA2608422C/en
Publication of WO2006125025A2 publication Critical patent/WO2006125025A2/en
Publication of WO2006125025A3 publication Critical patent/WO2006125025A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A composition for culturing stem cells is provided. The composition comprises an engineered purified collagen based matrix that has been formed under controlled conditions to have the desired microstructure and mechanical properties. The engineered purified collagen based matrix compositions of the present invention can be used alone or in combination with cells as a tissue graft construct to enhance the repair of damaged or diseased tissues.
PCT/US2006/019130 2005-05-16 2006-05-16 Engineered extracellular matrices control stem cell behavior Ceased WO2006125025A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2006247228A AU2006247228B2 (en) 2005-05-16 2006-05-16 Engineered extracellular matrices control stem cell behavior
GB0724345A GB2441268B (en) 2005-05-16 2006-05-16 Engineered extracellular matrices control stem cell behavior
CA2608422A CA2608422C (en) 2005-05-16 2006-05-16 Engineered extracellular matrices control stem cell behavior

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US68151105P 2005-05-16 2005-05-16
US68168905P 2005-05-16 2005-05-16
US68127805P 2005-05-16 2005-05-16
US68152205P 2005-05-16 2005-05-16
US60/681,689 2005-05-16
US60/681,522 2005-05-16
US60/681,278 2005-05-16
US60/681,511 2005-05-16

Publications (2)

Publication Number Publication Date
WO2006125025A2 WO2006125025A2 (en) 2006-11-23
WO2006125025A3 true WO2006125025A3 (en) 2007-06-07

Family

ID=37106236

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/019130 Ceased WO2006125025A2 (en) 2005-05-16 2006-05-16 Engineered extracellular matrices control stem cell behavior

Country Status (4)

Country Link
AU (1) AU2006247228B2 (en)
CA (1) CA2608422C (en)
GB (1) GB2441268B (en)
WO (1) WO2006125025A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2453452B (en) * 2006-05-16 2010-12-01 Purdue Research Foundation Three dimensional purified collagen matrices
US20070269476A1 (en) 2006-05-16 2007-11-22 Voytik-Harbin Sherry L Engineered extracellular matrices control stem cell behavior
CA2663722C (en) 2006-09-21 2014-12-09 Purdue Research Foundation Collagen preparation and method of isolation
US9867905B2 (en) 2007-12-10 2018-01-16 Purdue Research Foundation Collagen-based matrices with stem cells
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
WO2016033322A1 (en) 2014-08-27 2016-03-03 Purdue Research Foundation Office Of Technology Commercialization Collagen-based therapeutic delivery systems
WO2016172365A1 (en) 2015-04-21 2016-10-27 Purdue Research Foundation Office Of Technology Commercialization Cell-collagen-silica composites and methods of making and using the same
US12280176B2 (en) 2017-01-31 2025-04-22 Geniphys, Inc. Methods and compositions for matrix preparation
EP3615568A4 (en) 2017-04-25 2021-01-20 Purdue Research Foundation THREE-DIMENSIONAL (3D) TISSUE-BUILT MUSCLE FOR TISSUE RESTORATION
CN109224129B (en) * 2018-09-30 2021-09-24 四川大学华西医院 A skin defect repair material
CA3168904A1 (en) 2020-01-27 2021-08-05 Geniphys, Inc. Biologic filler for restoring and regenerating tissue
US20230119502A1 (en) * 2020-03-30 2023-04-20 Northeastern University Collagen Nucleation Inhibitors

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102237A2 (en) * 2001-06-15 2002-12-27 The Cleveland Clinic Foundation Tissue engineered mitral valve chrodae and methods of making and using same
WO2003068287A1 (en) * 2002-02-11 2003-08-21 Neocutis Sa Compositions comprising undifferentiated fetal cells for the treatment of skin disorders
WO2003087337A2 (en) * 2002-04-12 2003-10-23 Yale University Vascularized human skin equivalent
WO2006003442A2 (en) * 2004-07-05 2006-01-12 Ucl Business Plc Cell-independent fabrication of tissue equivalents
EP1674116A2 (en) * 2004-12-22 2006-06-28 DePuy Products, Inc. Self-assembling protein matrix prepared from natural extracellular matrices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102237A2 (en) * 2001-06-15 2002-12-27 The Cleveland Clinic Foundation Tissue engineered mitral valve chrodae and methods of making and using same
WO2003068287A1 (en) * 2002-02-11 2003-08-21 Neocutis Sa Compositions comprising undifferentiated fetal cells for the treatment of skin disorders
WO2003087337A2 (en) * 2002-04-12 2003-10-23 Yale University Vascularized human skin equivalent
WO2006003442A2 (en) * 2004-07-05 2006-01-12 Ucl Business Plc Cell-independent fabrication of tissue equivalents
EP1674116A2 (en) * 2004-12-22 2006-06-28 DePuy Products, Inc. Self-assembling protein matrix prepared from natural extracellular matrices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BRIGHTMAN ET AL.: "Time-lapse confocal reflection microscopy of collagen fibrillogenesis and extracellular matrix assembly in vitro", BIOPOLYMERS, vol. 54, 2000, pages 222 - 234, XP002428748 *

Also Published As

Publication number Publication date
CA2608422C (en) 2014-10-28
AU2006247228B2 (en) 2012-04-26
GB0724345D0 (en) 2008-01-30
WO2006125025A2 (en) 2006-11-23
AU2006247228A1 (en) 2006-11-23
GB2441268A (en) 2008-02-27
CA2608422A1 (en) 2006-11-23
GB2441268B (en) 2009-10-21

Similar Documents

Publication Publication Date Title
GB2453452A (en) Three dimensional purified collagen matrices
EP2061527B8 (en) Repair of cartilage tissue
WO2006125025A3 (en) Engineered extracellular matrices control stem cell behavior
WO2008106485A3 (en) Tissue-engineered silk organs
WO2007035363A3 (en) Compositions and methods for the augmentation and repair of defects in tissue
WO2007147014A8 (en) Method and systems for using biopolymer-based beads and hydrogels
WO2007106200A3 (en) Expansion and differentiation of neural stem cells under low oxygen conditions
EP2727998A3 (en) Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
WO2007030811A3 (en) Tissue engineering methods and compositions
EP2420567A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
WO2011071476A3 (en) Compositions and methods for engineering cells
WO2010017562A3 (en) Induced pluripotent stem cells
IL186814A0 (en) Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs and organisms
EP3461507A8 (en) Cell-scaffold constructs
WO2007115336A3 (en) A shape-based approach for scaffoldless tissue engineering
WO2010062911A3 (en) Compositions and methods of functionally enhanced in vitro cell culture system
EP2049130A4 (en) Soft tissue filler composition comprising autologous dermis-derived cell culture product and hyaluronic acid
WO2005081870A3 (en) Intervertebral disc repair, methods and devices therefor
WO2010086856A3 (en) Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
WO2007064846A3 (en) COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION
WO2008008550A3 (en) Compositions and methods for growing human embryonic stem cells
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
WO2006076627A3 (en) Methods and compositions related to modulating the extracellular stem cell environment
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
AU2005221582A8 (en) Tissue repair with multipotent cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2608422

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006247228

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 0724345

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20060516

WWE Wipo information: entry into national phase

Ref document number: 0724345.4

Country of ref document: GB

NENP Non-entry into the national phase

Ref country code: RU

ENP Entry into the national phase

Ref document number: 2006247228

Country of ref document: AU

Date of ref document: 20060516

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 06760040

Country of ref document: EP

Kind code of ref document: A2